TCTAP A-138 Effects of Mindfulness-based Stress Reduction on Components of the Metabolic Syndrome in Patients with Coronary Heart Disease: A Randomized Controlled Trial

The metabolic syndrome is now regarded as a contributor to coronary heart disease (CHD), and components of the syndrome have thought to be potential therapeutic targets. Previous study indicates neurotransmitter activation related to psychosocial stress as a key factor to the metabolic syndrome. The